Haoxi Health Technology Limited (HAO) Income Statement
HAO 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsHAO revenue and net income
Where HAO's revenue goes
2025Each bar shows an amount and its share of revenue. HAO kept 11.8% of revenue as net income.
HAO profit margins
HAO growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −32.4% | +5.1% | +20.6% | — |
| Gross profit | −66.3% | −23.4% | +8.9% | — |
| Operating income | −216.5% | — | — | — |
| Net income | +200.1% | +58.7% | +66.4% | — |
| EPS (diluted) | −85.4% | +63.5% | +234.3% | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
HAO quarterly EPS vs estimates
Haoxi Health Technology beat the analyst EPS estimate in 1 of the last 2 quarters.
HAO income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $32.8M | $48.5M | $48.5M | $28.2M | $16.2M | $12.8M |
| Cost of revenue | $31.9M | $45.8M | $45.8M | $26.2M | $15.5M | $12.2M |
| Gross profit | $927,750 | $2.8M | $2.8M | $2.1M | $648,721 | $605,577 |
| Research & development | $79,544 | $79,985 | $79,985 | $58,161 | $102,524 | $62,645 |
| Sales, general & admin | $2.8M | $953,144 | $953,144 | $808,094 | $277,429 | $212,378 |
| Total operating expenses | $2.9M | $1.0M | $46.8M | $866,255 | $379,953 | $275,023 |
| Operating income | −$2.0M | $1.7M | $2.8M | $1.2M | $268,770 | $330,550 |
| Interest income | — | — | $76,096 | $0 | — | — |
| Interest expense | $45,956 | $41,186 | $41,186 | $20,902 | $9,961 | $5,270 |
| Income before taxes | $4.1M | $1.7M | $1.7M | $1.2M | $259,595 | $325,284 |
| Income taxes | $270,744 | $443,582 | −$1.3M | $220,653 | $15,008 | $21,219 |
| Net income | $3.9M | $1.3M | $1.3M | $969,752 | $244,587 | $304,065 |
| EBITDA | $4.6M | $1.8M | $2.8M | $1.2M | $271,770 | $330,965 |
| EPS (diluted) | $8.35 | $57.15 | $2.19 | $1.91 | $0.49 | $0.02 |
| Gross margin | 2.8% | 5.7% | 5.7% | 7.3% | 4.0% | 4.7% |
| Operating margin | −6.1% | 3.5% | 5.7% | 4.2% | 1.7% | 2.6% |
| Net margin | 11.8% | 2.7% | 2.7% | 3.4% | 1.5% | 2.4% |
| Jun '26 | Mar '26 | Sep '25 | Mar '25 | Sep '24 | Jun '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Jun '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.0M | $33.8M | $8.8M | $24.0M | $25.0M | $25.0M | $23.5M | $11.8M | $19.1M | $9.5M | $9.2M | $8.1M |
| Cost of revenue | $22.0M | $32.2M | $8.4M | $23.5M | $23.5M | $23.5M | $22.3M | $11.2M | $17.7M | $8.9M | $8.4M | $7.8M |
| Gross profit | −$967,375 | $1.6M | $447,357 | $480,393 | $1.5M | $1.5M | $1.2M | $600,694 | $1.3M | $665,919 | $730,230 | $324,360 |
| Research & development | $43,187 | $61,170 | $11,988 | $67,556 | $49,143 | — | $30,842 | $15,421 | $34,320 | $17,160 | $23,842 | $51,262 |
| Sales, general & admin | $1.5M | $7.2M | $2.3M | $540,188 | $600,970 | — | $352,174 | $131,915 | $576,676 | $247,664 | $213,596 | $138,714 |
| Total operating expenses | $1.5M | $7.3M | $2.3M | $607,744 | $650,113 | — | $383,016 | $192,988 | $614,250 | $307,125 | $237,634 | $189,976 |
| Operating income | −$2.5M | −$5.7M | −$1.9M | −$127,351 | $898,876 | $1.5M | $818,372 | $409,186 | $703,020 | $351,510 | $492,790 | $134,385 |
| Interest expense | $26,866 | — | $45,956 | — | $24,397 | — | $16,789 | — | $24,397 | — | $16,789 | $4,980 |
| Income before taxes | −$3.0M | −$6.5M | $4.1M | $2,077 | $935,021 | — | $800,228 | $400,114 | $704,358 | $352,179 | $486,046 | $129,798 |
| Income taxes | −$304,091 | $340,705 | $36,134 | $234,610 | $403,552 | −$529,802 | $40,030 | $20,015 | $181,652 | $90,826 | $39,000 | $7,504 |
| Net income | −$2.7M | −$6.9M | $4.1M | −$232,533 | $531,469 | $529,802 | $760,198 | $380,099 | $522,706 | $261,353 | $447,046 | $122,294 |
| EBITDA | −$2.3M | −$5.4M | $4.2M | $11,612 | $958,401 | $1.5M | $829,956 | $414,978 | $709,708 | $354,854 | $494,496 | $135,885 |
| EPS (diluted) | — | — | $1.14 | −$0.13 | $0.41 | — | — | — | — | — | — | — |
| Gross margin | −4.6% | 4.7% | 5.1% | 2.0% | 6.2% | 6.2% | 5.1% | 5.1% | 7.0% | 7.0% | 8.0% | 4.0% |
| Operating margin | −11.8% | −16.8% | −21.2% | −0.5% | 3.6% | 6.2% | 3.5% | 3.5% | 3.7% | 3.7% | 5.4% | 1.7% |
| Net margin | −12.6% | −20.3% | 46.4% | −1.0% | 2.1% | 2.1% | 3.2% | 3.2% | 2.7% | 2.7% | 4.9% | 1.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in HAO's financial statements (latest annual report filed October 20, 2025); data from EODHD. Sales, general & administrative expenses include sales and marketing.
HAO financial results
In fiscal year 2025 (ended December 31, 2025), Haoxi Health Technology reported revenue of $32.8 million, down 32.4% from the year before. It had net income of $3.9 million (up 200.1%), a net profit margin of 11.8%. Diluted earnings per share came to $8.35. Over five years revenue grew at an average rate of 20.6% a year.
See the HAO stock overview for the latest quote and news, or the HAO chart for price history and technical indicators.
HAO income statement FAQ
What is Haoxi Health Technology's annual revenue?
Haoxi Health Technology reported total revenue of $32.8 million for fiscal year 2025, which ended on December 31, 2025. That was down 32.4% from $48.5 million the previous year.
Is Haoxi Health Technology profitable?
Yes. Haoxi Health Technology reported net income of $3.9 million in fiscal 2025, a net profit margin of 11.8%; its operating margin was −6.1%.
What is Haoxi Health Technology's gross margin?
Haoxi Health Technology's gross margin was 2.8% in fiscal 2025: for every $100 of revenue, Haoxi Health Technology kept $3 after the direct cost of its products and services.
How much does Haoxi Health Technology spend on research and development?
Haoxi Health Technology spent $0.1 million on research and development in fiscal 2025, 0.2% of revenue.
How fast is Haoxi Health Technology growing?
Revenue grew 20.6% a year on average over the last five fiscal years, from $12.8 million to $32.8 million.
What are Haoxi Health Technology's earnings per share?
Haoxi Health Technology earned $8.35 per diluted share in fiscal 2025, compared with $57.15 a year earlier.
When does Haoxi Health Technology's fiscal year end?
Haoxi Health Technology's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on October 20, 2025.